E-LIB Suche - Ergebnisse für: Nabors, Burt

1

A multicenter, phase 1, Adult Brain Tumor Consortium trial ..:

Ahluwalia, Manmeet S. ; Ozair, Ahmad ; Rudek, Michelle...
Cell Reports Medicine. , 2024

Link: https://doi.org/10.1016/..

2

Phase I and pharmacodynamic study of arsenic trioxide plus ..:

Ryu, Samuel ; Ye, Xiaobu ; Olson, Jeffrey J...
Neuro-Oncology Advances. 6 (2024) 1 - p. , 2024

Link: https://doi.org/10.1093/..

3

Deep-learning-based reconstruction of undersampled MRI to r..:

Rastogi, Aditya ; Brugnara, Gianluca ; Foltyn-Dumitru, Martha...
The Lancet Oncology. 25 (2024) 3 - p. 400-410 , 2024

Link: https://doi.org/10.1016/..

4

ACTION: a randomized phase 3 study of ONC201 (dordaviprone)..:

Arrillaga-Romany, Isabel ; Lassman, Andrew ; McGovern, Susan L...
Neuro-Oncology. 26 (2024) Supplement_2 - p. S173-S181 , 2024

Link: https://doi.org/10.1093/..

5

CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND R..:

Wen, Patrick ; Alexander, Brian ; Berry, Donald...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v97-v98 , 2023

Link: https://doi.org/10.1093/..

6

CTNI-51. A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF VORASID..:

Cloughesy, Timothy ; Mellinghoff, Ingo ; van den Bent, Martin...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v86-v87 , 2023

Link: https://doi.org/10.1093/..

7

CTIM-42. INB-200: PHASE 1 STUDY OF GENE MODIFIED AUTOLOGOUS..:

Lobbous, Mina ; Goswami, Trishna ; Lamb, Lawrence...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v72-v72 , 2023

Link: https://doi.org/10.1093/..

8

NCCN CNS tumor guidelines update for 2023:

Nabors, Burt ; Portnow, Jana ; Hattangadi-Gluth, Jona.
Neuro-Oncology. 25 (2023) 12 - p. 2114-2116 , 2023

Link: https://doi.org/10.1093/..

9

Attenuation Of Chronic Pain In Male And Female Mice Through..:

Sorge, Robert ; Guha, Abhishek ; Si, Ying...
The Journal of Pain. 24 (2023) 4 - p. 40-41 , 2023

Link: https://doi.org/10.1016/..

10

CTIM-35. INB-400 PHASE 1B/2 DRUG RESISTANT IMMUNOTHERAPY WI..:

Goswami, Trishna ; Lamb, Lawrence ; Rochlin, Kate.
Neuro-Oncology. 25 (2023) Supplement_5 - p. v70-v70 , 2023

Link: https://doi.org/10.1093/..

11

LTBK-06. IMPACT OF VORASIDENIB TREATMENT ON MUTANT IDH1 OR ..:

Wen, Patrick ; Mellinghoff, Ingo ; van den Bent, Martin...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v310-v311 , 2023

Link: https://doi.org/10.1093/..

12

CTIM-13. PHASE I CLINICAL TRIAL OF ONCOLYTIC HSV-1 M032, A ..:

Estevez-Ordonez, Dagoberto ; Stein, John ; Maleknia, Pedram...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v64-v64 , 2023

Link: https://doi.org/10.1093/..

13

IMMU-39. EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN GLIOBL..:

Stuhlmiller, Timothy ; Quinn, Jameson ; Awawda, Alaa...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v151-v151 , 2023

Link: https://doi.org/10.1093/..

14

MODL-06. THE GUT MICROBIOTA OF BRAIN TUMOR PATIENTS CAN IMP..:

Kim, Donggeon ; Sarvesh, Sujith ; Valbak, Olivia...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v299-v299 , 2023

Link: https://doi.org/10.1093/..

15

CTNI-17. APPLICATION OF THE GBM-X DATA PLATFORM TO ESTIMATE..:

Rahman, Rifaquat ; Trippa, Lorenzo ; Fell, Geoffrey...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v76-v77 , 2023

Link: https://doi.org/10.1093/..